ICER
ICER
  • ICER Analytics™
  • Donate
search
  • Who We Are
    • History & Impact
    • People
    • Independent Funding
    • Careers
    • Frequently Asked Questions (FAQs)
  • Our Approach
    • Methods & Process
    • Policies
  • Engage with ICER
    • Patients
    • Clinicians
    • Manufacturers
    • Prospective Employees
    • Committees & Boards
  • News & Insights
    • Press Releases
    • Commentaries
    • Journal Articles
    • Weekly View
  • Explore Our Research
    • Assessments
    • Policy Papers
    • ICER Calendar
    • ICER ANALYTICS™
Explore Our Research / Assessments / Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

An assessment of sotatercept

Public Meeting
December 2023

Assessment Status

Open

Public Comments

OpenView

Closed

Upcoming Milestone

Revised Scoping DocumentView

  • Overview
  • Full Timeline & Materials
  • Related Assessments & Articles

Interventions of Interest:

  • sotatercept (Merck & Co)

For questions please contact Yamaya Jean, Program Manager, at yjean@icer.org.

View the Key Stakeholder List.

Main Review
December 1, 2023

Midwest CEPAC

The Midwest CEPAC’s 2023 public meeting on pulmonary arterial hypertension.

 

Pulmonary Arterial Hypertension Meeting Agenda

Public Comment Period

See Full Timeline
05/15/2023 - 06/05/2023

Public Comments on Draft Scoping Document

Related Assessments & Policy Papers.

Woman_in_passing

Hypertrophic Cardiomyopathy

Oct 2021

Congestive Heart Failure

Nov 2015

ECMO

Feb 2016
05/15/2023

Draft Scoping Document

Download PDF

05/15/2023 - 06/05/2023

Public Comments on Draft Scoping Document

06/13/2023

Revised Scoping Document

06/20/2023

Research Protocol

Please find the research protocol here:

08/09/2023

Model Analysis Plan

09/25/2023

Draft Evidence Report

Having trouble viewing the report? Click here. 

 

09/25/2023 - 10/23/2023

Public Comments on Draft Evidence Report

11/14/2023

Evidence Report

12/01/2023

Evidence Presentation

01/08/2024

Final Evidence Report and Meeting Summary

Related Assessments & Policy Papers

Hypertrophic Cardiomyopathy

Oct 2021 CTAF

Congestive Heart Failure

Nov 2015

ECMO

Feb 2016

Related Press Releases

ICER to Assess Treatment for Pulmonary Arterial Hypertension

— Report will be subject of Midwest CEPAC meeting in December 2023; Draft Scoping Document open to public comment until June 5, 2023 —

Read More 05/15/2023
Go to Press Releases
Back to Top
  • Contact
  • Careers
  • Find a Report
  • Donate
  • ICER ANALYTICS™ LOGIN

OUR NEWSLETTER.

A weekly digest of the top news
on ICER and US drug pricing. Sign Up


CONTACT US

Institute for Clinical and Economic Review
14 Beacon Street, Suite 800, Boston, MA 02108
Get Directions

+1 (617) 528-4013

Email: info@icer.org

Media Inquiries: mediainquiries@icer.org

ICER
© ICER, 2023
  • Terms and Conditions
  • Privacy Policy
Twitter Linkedin
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT